Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carisbamate open-label extension in refractory partial seizures
NCT00210522Phase 2Completed
- Sponsor
- SK Life Science, Inc.
- Start
- May 2005
- Primary completion
- Jun 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of carisbamate in epilepsy, sponsored by SK Life Science, Inc.. Started May 2005; status: completed.
02
Drugs
carisbamate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00210522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00210522.